menu
    • menu

    Company profile for Candid Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Candid Therapeutics is pioneering a new frontier in autoimmune therapy with its innovative T-cell engager antibodies. By precisely directing T-cells to target and eliminate autoreactive B-cells, we aim to deliver transformative efficacy with enhanced safety. Our approach is rooted in rigorous scientific research and a deep understanding of immunological mechanisms, allowing us to develop therapies that offer significant advanc...
    Candid Therapeutics is pioneering a new frontier in autoimmune therapy with its innovative T-cell engager antibodies. By precisely directing T-cells to target and eliminate autoreactive B-cells, we aim to deliver transformative efficacy with enhanced safety. Our approach is rooted in rigorous scientific research and a deep understanding of immunological mechanisms, allowing us to develop therapies that offer significant advancements in the treatment of autoimmune diseases. Candid Therapeutics is committed to pushing the boundaries of immunotherapy to improve patient outcomes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Candid TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11622 El Camino Real, Suite 150 San Diego, CA 92130
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.candidrx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Candid Therapeutics Named 2025 Endpoints 11 Honoree
    Candid Therapeutics Named 2025 Endpoints 11 Honoree

    19 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-19/candid-therapeutics-recognized-as-a-2025-endpoints-11-honoree

    PHARMAWEB
    19 Sep 2025
    Share Share
    Candid Therapeutics to Present in Investor & Policy Conferences
    Candid Therapeutics to Present in Investor & Policy Conferences

    28 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250828631191/en/Candid-Therapeutics-to-Participate-in-Investor-and-Policy-Conferences

    BUSINESSWIRE
    28 Aug 2025
    Share Share
    Candid Moves T-Cell Engagers Into Autoimmune Trials
    Candid Moves T-Cell Engagers Into Autoimmune Trials

    20 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250619757578/en/Candid-Therapeutics-Advances-Portfolio-of-Novel-T-Cell-Engagers-into-Five-Autoimmune-Diseases-for-Clinical-Evaluation

    BUSINESSWIRE
    20 Jun 2025
    Share Share
    Candid steps up TCE deal momentum with $925M WuXi partnership
    Candid steps up TCE deal momentum with $925M WuXi partnership

    07 Jan 2025

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20250106155648/en/Candid-Therapeutics-Enters-into-Agreement-with-WuXi-Biologics-on-Trispecific-T-cell-Engager

    BUSSINESSWIRE
    07 Jan 2025
    Share Share
    Candid Therapeutics & Ab Studio Collaborate on T-Cell Engagers
    Candid Therapeutics & Ab Studio Collaborate on T-Cell Engagers

    16 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241216164600/en

    BUSINESSWIRE
    16 Dec 2024
    Share Share
    Candid Therapeutics & EpimAb Collaborate on T-Cell Engagers
    Candid Therapeutics & EpimAb Collaborate on T-Cell Engagers

    16 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241216821817/en

    BUSINESSWIRE
    16 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search